Table 2.
Anthropometric and demographic data, risk factors, and medications of the sedentary (SG) and the concurrent aerobic and resistance training groups (CART)
| Variables | SG (N = 20) | CART-G (N = 21) | P |
|---|---|---|---|
| Age (years) | 52.1 ± 7.3 | 49.5 ± 6.1 | 0.21 |
| Height (cm) | 167 ± 0.1 | 169 ± 0.1 | 0.53 |
| Weight (kg) | 85 ± 18.6 | 82.2 ± 19.4 | 0.63 |
| BMI (kg/m2) | 30.4 ± 5.8 | 30.1 ± 5.4 | 0.28 |
| Duration type 2 diabetes (years) | 7.4 ± 5.8 | 5.7 ± 5.5 | 0.17 |
| SBP rest (mmHg) | 131.1 ± 16.5 | 129.7 ± 15.8 | 0.79 |
| DBP rest (mmHg) | 89.4 ± 8.0 | 92 ± 11.1 | 0.40 |
| HR (bpm) | 83 ± 12.5 | 85.5 ± 13.1 | 0.54 |
| Risk factors % (n) | |||
| Tabagism | 0 | 0 | – |
| CAD family history | 20 (4) | 23.8 (5) | 1.00 |
| Dyslipidemia | 50 (10) | 42.8 (9) | 0.75 |
| Obesity | 55 (11) | 38 (8) | 0.35 |
| SAH | 60 (12) | 47.6 (10) | 0.53 |
| Medications | |||
| Hypoglycemiants % (n) | |||
| Biguanides | 95 (19) | 85.7 (18) | 0.60 |
| Sulfonylurea | 45 (9) | 47.6 (10) | 1.00 |
| Antihypertensive | |||
| ACE I inhibitors | 15 (3) | 14.3 (3) | 1.00 |
| Renin inhibitors | 1.00 | ||
| ARAII | 25(5) | 20 (4) | 0.71 |
| Diuretics | 5 (1) | 9.5 (2) | 0.60 |
| Hypolipemiant | |||
| Estatins | 15 (3) | 19 (4) | 1.00 |
| Fibrates | 10 (2) | – | 0.23 |
Data are reported as means ± SD. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, CAD cardiovascular disease, SAH systemic arterial hypertension, ACE I angiotensin converting enzyme I inhibitor, ARAII angiotensin II receptor antagonists